NCT04928482

Brief Summary

Approximately 15,000 Veterans are hospitalized for stroke each year with new cases costing an estimated $111 million for acute inpatient, $75 million for post-acute inpatient, and $88 million for follow-up care over 6 months post-stroke. The investigators have previously established the effectiveness of a backward walking training program to improve gait and balance in post-stroke Veterans. To best serve Veterans in this era of personalized medicine, there is a current need to determine the appropriate training dose as well as which post-stroke Veterans would most benefit. This study addresses both needs as it will 1) test responses to two different doses (18 vs. 27 sessions) of backward walking training and 2) assess brain activity, measured by magnetic resonance imaging, before and after training intervention to determine its ability to predict rehabilitation response as well as brain mechanisms of behavioral change.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
8mo left

Started Nov 2021

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Nov 2021Dec 2026

First Submitted

Initial submission to the registry

June 9, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 16, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

November 8, 2021

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

4.9 years

First QC Date

June 9, 2021

Last Update Submit

April 2, 2026

Conditions

Keywords

RehabilitationGaitPhysical Therapy ModalitiesMagnetic Resonance ImagingPostural BalanceAccidental Falls

Outcome Measures

Primary Outcomes (5)

  • Change in the time to complete the 10 Meter walk Test

    Gait speed will be measured with the 10-Meter Walk Test. Individuals will be given a 3 meter warm-up distance for walking, preceding the 10 meter distance and 3 meters beyond the 10 meters to continue walking. The time that it takes to traverse the 10 meters at the subject's usual pace will be recorded.

    Change from baseline to end of study intervention (six or nine weeks depending on intervention arm)

  • Change in the time to complete the Three-Meter Backward Walk Test

    BW Speed will be assessed with the 3-Meter Backward Walk test (3MBWT). The test consists of a 1 meter warm-up distance, a timed 3 meter distance, followed by an additional 1 meter to continue walking. An average of two trials will be recorded.

    Change from baseline to end of study intervention (six or nine weeks depending on intervention arm)

  • Change in the Functional Gait Assessment

    A 10-item clinical gait and balance test of dynamic activities. Reported scores range from 0 to 30 with a larger number representing a better score.

    Change from baseline to end of study intervention (six or nine weeks depending on intervention arm)

  • Change in the Activity-Specific Balance Confidence Scale

    This 16-item self-report measure is used to assess perceived efficacy (self-reported confidence) in maintaining balance while performing a number of activities common in community-dwelling older adults. This scale is reported as an average of the 16 items from 0% to 100% with a larger number representing a better score.

    Change from baseline to end of study intervention (six or nine weeks depending on intervention arm)

  • Change in the Berg Balance Scale

    This tool consists of 14 items that assesses static and dynamic standing balance, ability to sit, stand up and transfer. The range of this scale is 0-56 with a larger number representing a better score.

    Change from baseline to end of study intervention (six or nine weeks depending on intervention arm)

Secondary Outcomes (5)

  • Change in the time to complete the 10 Meter walk Test

    Change from baseline through study completion, an average of 7 months.

  • Change in the time to complete the Three-Meter Backward Walk Test

    Change from baseline through study completion, an average of 7 months.

  • Change in the Functional Gait Assessment

    Change from baseline through study completion, an average of 7 months.

  • Change in the Activity-Specific Balance Confidence Scale

    Change from baseline through study completion, an average of 7 months.

  • Change in the Berg Balance Scale

    Change from baseline through study completion, an average of 7 months.

Study Arms (2)

27 session group

EXPERIMENTAL

Participants in this arm will receive 27 sessions of backward walking training.

Behavioral: Backward Walking Training

18 session group

ACTIVE COMPARATOR

Participants in this arm will receive 18 sessions of backward walking training.

Behavioral: Backward Walking Training

Interventions

Participants will receive 27 sessions of backward walking training. Each session wil consist of 20 minutes of gait training on a treadmill and 20 minutes of gait training over ground.

27 session group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Berg Balance Scale \< 45
  • Self-selected 10 meter gait speed \< 0.8 m/s
  • Diagnosis of unilateral stroke
  • \> 2 months \< 4 months post-stroke
  • Able to ambulate at least 10 feet with maximum 1 person assist
  • Medically stable

You may not qualify if:

  • Presence of neurological condition other than stroke
  • Serious cardiac conditions (hospitalization for myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living)
  • Anyone meeting New York Heart Association criteria for Class 3 or Class 4 heart disease will be excluded
  • Severe arthritis or orthopedic problems that limit passive ranges of motion of lower extremity (knee flexion contracture of -10 degrees, knee flexion ROM \< 90 degrees, hip flexion contracture \> 25 degrees, and ankle plantar flexion contracture \> 15 degrees)
  • Severe hypertension with systolic greater than 200 mmHg and diastolic greater than 110 mmHg at rest
  • Pain upon ambulation
  • Receiving physical therapy services for mobility and/or gait
  • Living in a skilled nursing facility
  • Any MRI contraindication, including but not limited to the presence of metal, MR sensitive implanted medical devices, or claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

North Florida/South Georgia Veterans Health System, Gainesville, FL

Gainesville, Florida, 32608-1135, United States

RECRUITING

Brooks Rehabilitation

Jacksonville, Florida, 32216, United States

NOT YET RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Dorian Kay Rose, PhD MS BS

    North Florida/South Georgia Veterans Health System, Gainesville, FL

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dorian K Rose, PhD MS BS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome Assessors will be masked to group assignment. Outcome Assessors will not deliver the intervention and will not be present in the building when the intervention is being delivered. Participants will be instructed to not reveal their group assignment to the outcome assessor.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized to receive either: 1) 27 sessions of backward walking training or 2) 18 sessions of backward walking training
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2021

First Posted

June 16, 2021

Study Start

November 8, 2021

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 8, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations